OTC Cough, Cold and Allergy Medicine Market growth graph to witness upward trajectory during 2021-2027

Market Overview:

Over the cough are the products which are used to relieve symptoms of cold, flu, and allergy, including nasal stuffiness and congestion, sneezing, runny noses, sore throat, and cough. The main causes of these symptoms are common cold, influenza virus, allergic rhinitis, fever and sinus infections. Global OTC Cough, Cold & Allergy Medicine Market is expected to grow in the forecasted period, in 2018 market size of the OTC Cough, Cold & Allergy Medicine was XX million and in 2028 is expected to reach at XX million with growing CAGR of XX%.

Market Dynamics:

Factor such as government initiatives, better healthcare facilities and increasing number of immunosuppressed individuals which are expected to boost the growth of the OTC Cough, Cold & Allergy Medicine Market. Furthermore, rising global geriatric population, laws enforcing consumer safety and increasing usage of cold & cough medications for minor issues is expected to boost the growth of the overall market. However, costs & prices with manufacturing process of the product are expected to hinder the growth of the OTC Cough, Cold & Allergy Medicine Market over the forecast period.

Market Players:

Sanofi-Aventis, Johnson & Johnson Service, Inc., Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., AstraZaneca Plc., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Prestige Brands Holdings, Inc., Procter & Gamble Co., Bristol-Myers Squib Co., Merck & Co., and Allergenare some of the prominent players in the OTC Cough, Cold & Allergy Medicine Market.

Request for Sample with Complete TOC and Figures & Graphs @ https://www.trendsmarketresearch.com/report/sample/3243

Market Segmentation:

Asia-Pacificexpected to grow with a fastest CAGR over forecast period majorly due to government initiatives, dropping air quality which results in increase in pollution and higher occurrence of respiratory ailments. Furthermore, rapid adoption of OTC medicines ,convenience of purchase and cost-efficiency is also expected to boost the growth of the overall market in this region.Countries such as China and Japan are expected to account for the largest market share over the forecast period.

Pharmacies segment of sales channel dominated the market in 2018 majorly due to increasing sales of allergy, cold & cough drugs.

Market segmented on the basis ofdrugtype:

• Antihistamine
• Expectorants
• Bronchodilators
• Antibiotics
• Others

Get Discount On The Purchase Of This Report @ https://www.trendsmarketresearch.com/checkout/3243/Single

Market segmented on the basis ofsales channel:

• Pharmacy
• Online
• Modern Trade
• Drug Store
• Others

Market segmented on the basis ofdosage:

• Liquid
• Capsule
• Tablet
• Lozenges
• Others

Market segmented on the basis of region:

– North America
• US
• Canada
• Mexico
– Europe
• UK
• Germany
• France
• Rest of Europe
– Asia-Pacific
• China
• Japan
• India
• Australia
• Rest of Asia-Pacific
– Latin America
• Brazil
• Rest of Latin America
– Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• Rest of MEA

Request For Report Description : https://www.trendsmarketresearch.com/report/otc-cough,-cold-and-allergy-medicine-market

Contact Us:
One Vincent Square
Westminster, London SW1P 2PN
United Kingdom
Email: sales@trendsmarketresearch.com
Website: https://www.trendsmarketresearch.com
Linkedin:https://www.linkedin.com/company/trends-market-research

Company Overview
Trends Market research We are a UK-based market intelligence company that operates out of its passion to help brands grow, discover, and transform. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

This release was published on openPR.